Diagnosis and treatment of cancer based on AVL9

Details for Australian Patent Application No. 2011229199 (hide)

Owner immatics biotechnologies GmbH

Inventors Weinschenk, Toni; Fritsche, Jens; Walter, Steffen; Lewandrowski, Peter; Singh, Harpreet

Agent Pizzeys

Pub. Number AU-A-2011229199

PCT Pub. Number WO2011/113819

Priority 61/315,704 19.03.10 US; 1004551.6 19.03.10 GB

Filing date 15 March 2011

Wipo publication date 22 September 2011

International Classifications

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 35/00 Antineoplastic agents

C07K 7/08 Peptides having 5 to 20 amino acids in a fully defined sequence

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/113819 Priority application(s): WO2011/113819

1 November 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Novel Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011229200-A process using Grignard reagents

2011229177-Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers